a kid of 5 years is suffering from a cough whatt sfould i prescribe her
cough management children acute respiratory infection
Important clinical note: "Mild distress + fast breathing" in a 5-year-old is a RED FLAG that requires proper clinical assessment before prescribing. This is not a simple viral cold - tachypnea raises the possibility of pneumonia or bronchitis, not just an upper respiratory infection.
| Parameter | Outpatient safe | Needs admission |
|---|---|---|
| O2 saturation (SpO2) | ≥95% on room air | <90% |
| Respiratory rate (at 5 yrs) | <40 breaths/min | >40 + retractions |
| Able to drink/feed | Yes | No |
| Appearing toxic | No | Yes (grunting, nasal flaring) |
| Chest X-ray | Clear or mild changes | Consolidation/effusion |
Amoxicillin (high-dose) 75-90 mg/kg/day divided every 12 hours for 5-7 days
- Targets Streptococcus pneumoniae (most common bacterial cause under 5)
- Penicillin allergy: use Azithromycin 10 mg/kg on Day 1, then 5 mg/kg/day on Days 2-5
| Drug | Dose | Duration | Notes |
|---|---|---|---|
| Amoxicillin | 75-90 mg/kg/day ÷ 12h | 5-7 days | First-line, pneumococcal cover |
| Azithromycin | 10 mg/kg Day1, 5mg/kg Days 2-5 | 5 days | Atypical or penicillin allergy |
| Amoxicillin-clavulanate | 90 mg/kg/day ÷ 8h | 5-7 days | If critically ill or no response to amoxicillin |
Amoxicillin oral suspension 250 mg/5 mL
Dose: 75-90 mg/kg/day in 2 divided doses (every 12 hours)
For a ~18-20 kg child at 5 yrs: approximately 375-450 mg per dose
Duration: 5-7 days
+ Paracetamol 250 mg (syrup/suppository) every 6 hours as needed for fever
+ Oral rehydration and rest
Disclaimer: This is a clinical support guide, not a substitute for direct patient examination. The tachypnea in this child must be evaluated in person before finalizing management. Always use local antibiogram data and institutional guidelines.
i can i differientiate asthama and pneumonia
| Feature | Asthma | Pneumonia |
|---|---|---|
| Onset | Episodic, recurrent attacks | Single acute episode (days) |
| Previous episodes | Yes - same pattern before | Usually first time |
| Trigger | Cold air, exercise, allergens, smoke | Preceding viral URTI, sick contacts |
| Family history | Asthma, eczema, hay fever (atopy) | Not usually relevant |
| Personal history | Eczema, allergic rhinitis | None required |
| Fever | Absent or mild (if triggered by viral infection) | Usually HIGH fever (>38.5°C) |
| Cough character | Dry, paroxysmal, worse at night | Productive/moist, constant |
| Time of symptoms | Often worse at night/early morning | Continuous day and night |
| Response to salbutamol | Significant improvement | Little or no improvement |
| Sign | Asthma | Pneumonia |
|---|---|---|
| Temperature | Normal or low-grade | High fever common |
| Auscultation | Diffuse bilateral wheeze (expiratory) | Localised crackles (crepitations), one area |
| Breath sounds | Prolonged expiration, diffuse wheeze | Bronchial breathing, reduced air entry focally |
| Percussion | Resonant (hyperinflation) | Dull over consolidated area |
| Vocaltremor/egophony | Normal | Increased over consolidation |
| Nasal flaring/retractions | Present in severe attack | Present in moderate-severe pneumonia |
| Distribution | Bilateral, symmetric | Usually unilateral and focal |
Key pearl: If you hear wheeze - think asthma. If you hear focal crackles + dullness - think pneumonia. If you hear both, consider pneumonia triggering an asthma attack, or post-infectious bronchospasm.
| Test | Asthma | Pneumonia |
|---|---|---|
| Chest X-ray | Hyperinflation, flat diaphragm, NO consolidation | Consolidation / opacity (lobar or patchy), air bronchograms |
| SpO2 | Drops with attack, improves with bronchodilator | May be persistently low, less responsive to salbutamol |
| WBC / CRP | Normal or mildly elevated (steroids can raise WBC) | Elevated WBC, high CRP/ESR (if bacterial) |
| Sputum | Clear/white, eosinophils | Purulent, neutrophils, bacteria |
| Peak flow / spirometry | Reversible obstruction (FEV1 improves >12% post-bronchodilator) | May be reduced, but not reversible |
| Blood culture | Negative | May be positive (S. pneumoniae etc.) |
Note: A normal CXR does NOT rule out pneumonia in early stages - clinical judgment matters. Conversely, leukocytosis can occur in asthma (due to steroids/catecholamines) and does NOT automatically mean infection. - Rosen's Emergency Medicine
| Treatment trial | Asthma | Pneumonia |
|---|---|---|
| Salbutamol (albuterol) nebulisation | Clear improvement in wheeze and distress within 15-20 min | Minimal or no improvement |
| Antibiotics | No effect on symptoms | Improvement over 48-72 hours |
| Systemic steroids | Rapid improvement | No acute benefit |
| Feature | Asthma | Pneumonia |
|---|---|---|
| Nature | Airway inflammation + bronchoconstriction (reversible) | Alveolar infection + consolidation |
| Key symptom | Wheeze, chest tightness | Fever, productive cough |
| Key sign | Bilateral expiratory wheeze | Focal crackles, dullness |
| CXR | Hyperinflation, clear fields | Consolidation / opacity |
| WBC | Normal/mild increase | Elevated (bacterial) |
| Bronchodilator | Works well | Does not help |
| Antibiotics | Not needed | Essential (if bacterial) |
| Atopy history | Present | Absent |
| Recurrence | Yes | Usually single episode |
Child with cough + respiratory distress
|
+----- Is there HIGH fever? ------+
| |
No Yes
| |
Wheeze bilateral? Focal crackles/dullness?
| |
YES -> Likely Asthma YES -> Likely Pneumonia
| |
Give salbutamol Get CXR + CBC/CRP
| |
Improves? -> Asthma confirmed Consolidation? -> Antibiotics
No improve? -> Get CXR
their risk factor
| Factor | Detail |
|---|---|
| Atopy | Single most important predisposing factor. History of eczema, allergic rhinitis, or elevated IgE strongly predicts asthma |
| Airway hyperresponsiveness | Exaggerated bronchoconstriction to stimuli like cold air, exercise, or irritants |
| Genetic predisposition | Polygenic inheritance; risk increases if one parent has asthma; higher if both parents affected |
| Sex | Boys more affected in childhood; girls more affected after puberty |
| Ethnicity | Higher prevalence in certain ethnic groups (e.g., Black children in urban settings) |
| Factor | Detail |
|---|---|
| Indoor allergens | House dust mite, cockroach, pet dander (cats/dogs), indoor mold - most common sensitizers |
| Outdoor allergens | Pollens, outdoor fungi (seasonal) |
| Tobacco smoke | Active AND passive smoking (secondhand smoke in children is major) |
| Respiratory infections in early childhood | Viral LRTIs (especially RSV, rhinovirus) before age 3 can increase risk - but only in atopic children |
| Obesity | Mechanically reduces lung function and promotes airway inflammation |
| Occupational sensitizers | Flour dust, isocyanates, latex - relevant in adults |
| Socioeconomic status | Lower SES linked to more allergen exposure, less treatment access |
| Air pollution | Urban pollution, traffic fumes, sulfur dioxide |
| Cesarean section / early antibiotic use | Alters gut microbiome, may reduce immune regulation (hygiene hypothesis) |
These do NOT cause asthma, but provoke symptoms in people who already have it:
| Risk Factor | Mechanism |
|---|---|
| Young age (<5 years) / Old age (>65) | Immature or waning immunity; most deaths from pneumonia in these groups |
| Malnutrition | Impairs cell-mediated immunity, mucociliary clearance, and phagocyte function |
| HIV/AIDS | Profound T-cell depletion; susceptible to PCP, TB, bacterial pneumonia |
| Chronic immunosuppression | Steroids, chemotherapy, biologics |
| Genetic immune disorders | Common variable immunodeficiency, WBC production disorders, multiple myeloma |
| Cystic fibrosis | Impaired mucociliary clearance, chronic Pseudomonas colonization |
| Sickle cell disease | Functional asplenia, impaired opsonization |
| Neurological disease / dementia | Impaired gag reflex → aspiration |
| Alcohol use disorder | Depresses cough reflex, neutrophil function, ciliary motility |
| Risk Factor | Mechanism |
|---|---|
| Crowded living conditions | Daycare, boarding schools, prisons, shelters - facilitate droplet spread |
| Smoking (active + passive) | Damages cilia, increases oropharyngeal colonization |
| Poor dental hygiene | Increases oropharyngeal bacterial load |
| Unvaccinated status | No protection against S. pneumoniae (PCV), H. influenzae (Hib), influenza |
| Aspiration risk | Gastric reflux (GERD), seizure disorder, altered consciousness, post-anesthesia |
| Hospitalization / intubation | Hospital-acquired and ventilator-associated pneumonia |
| Male sex | Slightly higher incidence across all age groups |
| Asthma | Pneumonia | |
|---|---|---|
| Most important RF | Atopy (personal/family) | Young age + malnutrition / immunosuppression |
| Genetic link | Strong (polygenic) | Moderate (immune gene disorders) |
| Environmental exposure | Allergens, pollution, smoke | Crowding, sick contacts, unvaccinated |
| Infection role | Trigger (not cause) | Direct cause |
| Vaccination effect | No vaccine exists | PCV13, Hib, influenza vaccines protect |
| Obesity | Increases risk | Increases severity |
| Smoke | Major trigger/risk | Increases susceptibility |
| Age peak | Childhood (boys), young adults | <5 yrs and >65 yrs |
| Modifiable factors | Allergen avoidance, no smoking | Vaccination, nutrition, hygiene |
in which case cefuroxime id cod